Mitral valve repair in papillary muscle rupture

Umar Imran Hamid1, Rezan Aksoy1, Peyman Sardari Nia1

  • 1Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.

Insights

Papillary muscle rupture (PMR) after heart attack causes severe mitral regurgitation (MR). Treatment options include surgery or transcatheter devices, but long-term outcomes require further study.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Papillary muscle rupture (PMR) is a life-threatening mechanical complication of myocardial infarction (MI).
  • PMR leads to severe mitral regurgitation (MR), often causing cardiogenic shock and pulmonary edema.
  • This condition necessitates urgent medical and surgical interventions.

Purpose of the Study:

  • To review current management strategies for papillary muscle rupture (PMR) following myocardial infarction (MI).
  • To compare surgical interventions (mitral valve repair vs. replacement) and emerging transcatheter device therapies.
  • To emphasize the importance of a multidisciplinary mitral heart team approach.

Main Methods:

  • Review of existing literature on PMR and mitral regurgitation (MR) management.
  • Analysis of outcomes associated with surgical mitral valve repair and replacement.
  • Evaluation of the role of transcatheter devices as a bridge to recovery or treatment.

Main Results:

  • Surgical mitral valve repair may offer better left ventricular function but carries risks of failure and longer cross-clamp times.
  • Mitral valve replacement is an alternative, with concomitant coronary revascularization potentially improving outcomes.
  • Transcatheter devices present a novel approach, but long-term efficacy data are pending.

Conclusions:

  • Management of PMR requires careful consideration of multiple treatment modalities.
  • A dedicated mitral heart team is crucial for optimal patient management.
  • Further long-term data are needed to compare the efficacy of surgical versus transcatheter interventions.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
37
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
20
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
27
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
53
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
34